España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Rolando García
Benzinga Staff Writer
About
Rolando is a Benzinga Staff Writter specialized in Cannabis and Economy. He is also a scientific researcher and professor, holds a PhD in Economics, and a degree in Sociology
States Without Legal Cannabis Are Missing Out On Billions In Annual Tax Revenue, New Analysis Shows
Cannabis tax revenue is transforming state economies, with over $19 billion raised so far. States like California and Colorado direct cannabis tax revenue to education.
Only 3% Of Cannabis Consumed In Canada Came From Illicit Sources, National Survey Shows
Discover key insights from the Canadian Cannabis Survey 2024: legal access soars, smoking declines, and youth usage remains stable. Learn more about evolving cannabis trends in Canada.
New York Medical Cannabis Industry Challenges The State's System: $20M Fee Per Operator At Stake
The NYMCIA challenges New York's $20 million cannabis license fee in court, arguing it's unconstitutional and unfair to cannabis operators.
Benzinga's Javier Hasse Recognized As 'Cannabis Journalist Of The Year' At Emjays International Awards In Vegas
Benzinga's Javier Hasse wins Cannabis Journalist of the Year at Emjays International Cannabis Awards 2024 in Las Vegas, celebrating his industry contributions.
Attorney Behind Same-Sex Marriage Revives Landmark Marijuana Case: 'Congress Has Abandoned The Goal Of Eradicating Cannabis'
Massachusetts cannabis businesses, led by David Boies, challenge federal cannabis laws in a crucial 1st Circuit appeal.
GOP Of Texas Gears Up To Battle Cannabis Legalization
Texas Lt. Gov. Dan Patrick proposes Senate Bill 3 to ban THC products, intensifying the state's crackdown on cannabis reforms. They face local resistance.
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.
Michigan's $10 Billion Cannabis Boom: Insights On Building A Thriving Industry
How Michigan built a $10B cannabis market in just five years by tackling regulation, illicit trade and lab testing challenges...
Illinois New Hemp Regulations Delayed After Industry Members Voice Concerns
Illinois delays proposed hemp regulations following industry backlash over inspections, fees, and social equity concerns.
NASDAQ-Listed High Tide Under The Magnifying Glass: Key Insights For Cannabis Investors
High Tide Inc. (NASDAQ: HITI) surges to $3.55, breaking key resistance levels on high volume. In this article, we analyze High Tide using technical indicators
Nebraska's Two-Front War On Cannabis
Nebraska: AG Mike Hilgers leads the fight against cannabis rescheduling, representing the state in the DEA hearing with prohibitionist SAM.
EXCLUSIVE: Why Cannabis Industry Workers And Employees Should Think About 401(k) Plans
GreenPath 401(k) is offering retirement planning for cannabis industry workers and employers with compliant solutions.
DEA Sued For Allegedly Hiding Emails With Anti-Marijuana Group
Attorney Matt Zorn has sued the DEA for not disclosing records on its communications with anti-cannabis group SAM
DEA LIVE Hearings On Marijuana Rescheduling, What To Expect
DEA's marijuana rescheduling hearings could reshape cannabis policy, easing research and tax rules while stopping short of full legalization.
Mexico President Claudia Sheinbaum To Trump: 'Neither Threats Nor Tariffs' Will Solve Your Fentanyl Crisis
Mexico: Sheinbaum tells Trump the fentanyl crisis needs cooperation, not tariffs, emphasizing U.S. public health and shared responsibilities.
Cannabis Advocates Did The Draft For Trump To Make Things Right For Prohibition Victims
The Drug Policy Alliance (DPA) has unveiled a comprehensive draft of an executive order aimed at transforming federal cannabis policy.
Prohibitionist Group Denies Collusion Allegations Ahead Of DEA Cannabis Rescheduling Hearing
SAM denies collusion with the DEA amid cannabis rescheduling hearing allegations, calling the claims baseless distractions from the issue's merits.
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders.
Minnesota's Cannabis License Lottery Faces Legal Delays Over Rejections Dispute
Minnesota: cannabis license lottery is delayed following lawsuits from rejected applicants, raising concerns about the state's timeline
DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process
DEA denies allegations of improper talks with an anti-marijuana group during rescheduling, treats claims as "gossip" and requesting dismissal